MedPath

Mobile health for type 2 diabetes

Not Applicable
Completed
Conditions
Type 2 diabetes
Nutritional, Metabolic, Endocrine
Type 2 diabetes mellitus
Registration Number
ISRCTN14335124
Lead Sponsor
iverpool John Moores University
Brief Summary

2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/34836904/ (added 29/11/2021)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
125
Inclusion Criteria

1. Clinical Diagnosis of T2D within the previous 5–24 months
2. Aged 40 - 75 years
3. Treating diabetes with only Metformin or lifestyle modifications (diet and exercise)
4. For those prescribed Metformin: Stable dose for 3-months or more

Exclusion Criteria

1. HbA1c >10% (>86mmol/mol)
2. Blood pressure >160/100 mmHg
3. Prescription of oral antidiabetic drug other than Metformin
4. Prescription of Insulin
5. Unstable angina
6. Myocardial infarction within the previous 3 months
7. Transient ischemic attack (TIA) in the previous 6 months
8. Heart failure >= class 2
9. Inability to increase level of activity
10. Pregnancy or planning to become pregnant
11. <6 months postpartum or stopped breastfeeding <1 month before recruitment
12. Not owning a smartphone/ or having no data plan or access to WiFi
13. Currently meeting the recommended exercise guidelines (150 min of moderate intensity exercise per week)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Feasibility outcomes:<br>1. The number of adults with newly diagnosed T2D that are eligible to participate<br>2. The proportion of these who would be willing to take part in this trial (i.e. recruitment rate), and their characteristics <br>3. The number of participants retained at 12-months (i.e. participant drop-out)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath